The clinical progress of 532 patients who were treated for ischemic heart disease by coronary bypass grafting during a five-year period was studied. All patients had at least 50% luminal narrowing of one BYPASS SURGERY in the management of atherosclerotic heart disease urgently requires, but presently lacks, precise definition. Although many reports indicate that operation can be conducted with a relatively low mortality and is accompanied by excellent short-term relief of symptoms, little information is available on the subsequent course of surgical patients or, for purposes of comparison, on the course of patients treated by alternative methods. The needed insight may be provided by prospective, randomized studies of treatment but, unfortunately, these studies are not yet available.
THE ROLE OF CORONARY ARTERY
BYPASS SURGERY in the management of atherosclerotic heart disease urgently requires, but presently lacks, precise definition. Although many reports indicate that operation can be conducted with a relatively low mortality and is accompanied by excellent short-term relief of symptoms, little information is available on the subsequent course of surgical patients or, for purposes of comparison, on the course of patients treated by alternative methods. The needed insight may be provided by prospective, randomized studies of treatment but, unfortunately, these studies are not yet available.
Meanwhile, much useful information can be obtained from a detailed retrospective analysis of experience. This method, despite its inherent limitations, has been applied successfully in assessing the results of cardiovascular surgery in many forms of congenital and acquired heart disease.'-" Admittedly, the assessment of coronary artery surgery is more difficult because the underlying disease tends to progress after treatment, and because angina pectoris, one of the prime functional expressions of the disease, tends to be highly personal and subjective in nature. In addition, surgical techniques and results vary widely, and surgical patients are not uniform in either extent of disease or irreversible impairment of ventricular function. Yet, when a defined subset of patients is considered, as in the following study, both the benefits and risks of coronary artery surgery become more clearly evident.
We relate herein our total experience in treating atherosclerotic heart disease in patients with relatively stable, disabling angina pectoris. Revascularization of obstructed coronary arteries was performed exclusively by means of venous bypass grafts. An analysis of the postoperative and time-related late mortality, the postoperative graft patency, and the time-related functional state of patients forms the basis of this report.
SURVIVAL AFTER CORONARY ARTERY SURGERY pectoris (NYHA Functional Class III and IV) received aortato-coronary artery vein bypass grafts (214 single, 260 double, 58 triple) at the University of Oregon Medical School, St. Vincent, and Portland Veterans Administration Hospitals from December 1968, to July 1973. Specifically excluded from analysis were other surgical patients characterized as follows: patients with unstable and accelerated angina; patients with coexisting valvular heart disease; patients with angina who also had dyspnea, orthopnea, and fluid retention and who were receiving both digitalis and diuretics for control of these symptoms; and patients with documented recent acute myocardial infarction at the time of operation. The study group contained 471 men (mean age 51.7 years) and 61 women (mean age 53.7 years).
Preoperative coronary arteriography was obtained in all cases. Most patients had both cinearteriograms and cut-film selective left and right coronary arteriograms in several projections.'2 Obstructions in the right, left main, left anterior descending, and circumflex arteries were graded as percent of lumen narrowing. For this analysis a 50% or greater reduction of luminal diameter was considered significant disease because a 50% reduction of luminal diameter corresponds to a 75% reduction of cross-sectional area and produces a reduction in blood flow. 13' 14 Left main disease was considered as double-vessel involvement irrespective of the state of distal branches. On this basis 113 patients had single-vessel involvement, 216 patients had double-vessel involvement and 203 patients had triple-vessel involvement. Postoperative coronary arteriography with assessment of graft patency was performed in 191 patients at a mean time of 6.0 months after operation.
Our previously described operative technique,`which included cardiopulmonary bypass with moderate hemodilution and mild hypothermia (32°C), was applied throughout the study with a few major changes as experience was gained. Beginning in 1972 distal anastomoses were performed with the aorta cross-clamped and the heart fibrillating; regular use of a left ventricular venting catheter was abandoned. Proximal anastomoses were performed with a partially occluding aortic clamp in the beating heart. During the first two years of this experience few vessels with 50-65% obstruction were grafted, and during the first three years diseased circumflex arteries were not grafted unless they appeared to provide the sole vascular supply to the posterior wall of the heart. Subsequently, all major vessels of 50% or greater obstruction have been grafted whenever feasible.
Follow-up data from the patients were collected bv personal physicians, by the authors, and by questionnaires and telephone interviews during each year of the study. The clinical results were determined from these data using the functional classification system (FC) of the New York Heart Association.16 Essentially where Pk-Pb is the difference, and SE and SEb are the corresponding standard errors, in cumulative yearly survival rate for any two groups a and b.
At the closing date of the study, December 15, 1973, a total of 38 patients had been lost to follow-up at various times after operation while the current status of 494 patients (93%) was known.
Results

Mortality
There were 18 postoperative deaths (prior to hospital discharge or within 30 days of operation), an operative mortality rate of 3.4%. A comparison of operative deaths and numbers treated each year ( fig.   1 ) showed much imporvement in operative morality, from 12% in the first year to 1.5% in the last year, and a steady increase in caseload. There were 17 late deaths from 5 weeks to 46 months after operation.
The causes of postoperative and late mortality are listed in table 1. A myocardial infarction that occurred during operation was the chief cause of postoperative mortality. By contrast, acute myocardial infarction could not be documented among the 13 late cardiac deaths. Since postmortem examinations were not obtained in the seven patients who died suddenly, it was not possible to confirm whether they had sustained fatal infarctions before reaching the hospital.
The time-related progress of the entire population was determined from a life table (table 2) and survival curve ( fig. 2 ). The one-year mortality rate, which included all operative deaths, was 5.6%. The mortality OPERAT Table 5 Modified Life The functional class of survivors was determined for each yearly interval after operation so that results for similar intervals of follow-up could be combined. The population was then further divided according to year of operation so that any change in results as experience was gained might become apparent. Table 7 lists patients by functional class, calendar year of operation, and interval after operation, and provides cumulative functional class totals for each yearly interval of follow-up. Figure 4 The treatment of ischemic heart disease can be analyzed in terms of the achievement of many desirable goals. These goals include extending the duration and quality of life, lessening or eliminating I   II  III & IV  i  II III & IV  I  IIIII & IV  I  II III & IV  I  I  II & angina, improving or stabilizing ventricular function and exercise capacity, and preventing arrhythmias, myocardial infarction, and sudden death. This study is confined to a description of the outcome of surgical treatment in two areas, time-related survival and symptomatic state. The study patients probably resemble the majority who currently undergo bypass surgery in this country in that they have incapacitating but relatively stable angina accompanied by arteriographic demonstrations of major coronary artery obstructions.
The four-year survival rate in this study was determined by actuarial methods to be 89%. However, this figure cannot be fairly compared with similar estimates in patients with angina who were treated nonoperatively because the studies available for comparison contain different or unknown proportions of high and low risk patients. Two early survival studies of patients with angina, those of Richards et al. ' 9 from the Massachusetts General Hospital and Block and coworkers20 from the Mayo Clinic, reported four-year survival rates of 75% and 63%, respectively. Since these survival rates were based on observations made prior to 1950, they may be taken as baseline estimates of the natural course of angina in hospitalized patients unmodified by present day diagnostic or therapeutic techniques. Several recent prospective studies of large groups in the general population have provided The percent of involved (0) and treated (0) vessels for each year of the study is shown above. another in terms of the proportion of involved vessels and four-year survival rates. The four-year survival rate in the Johns Hopkins study was 75% while in the Cleveland Clinic experience it was 69%. Our analysis of these data show that the difference in rates is not statistically significant. We have systematically excluded from our study patients with unstable angina, valvular heart disease, clinical congestive heart failure requiring therapy, and acute-phase myocardial infarction, and have thus obtained a relatively good-risk group. Both the Cleveland Clinic and the Johns Hopkins study either may have contained or did contain numbers of these high risk patients. Thus a comparison of survival between our surgical and their nonsurgical patients is probably not valid. Discrepancies between treatment groups, such as those noted above, are the reason why comparisons of retrospective analyses of treatment are so difficult. A wholly valid comparison is impossible because of biased and insufficient data and prospective randomized studies of surgical versus nonsurgical treatment are required to insure comparability of treatment groups. figure 3 . The differences in long term survival after operation for patients with one, two, or three vessels involved are small.
The excellent prognosis for survival in patients with single vessel disease has led some to question the need for surgical therapy in these individuals. 31 32 Surgical patients with single vessel disease in our study had an operative mortality rate of 0.9% and a four-year survival rate of 96%. Our study suggests that the role of surgical therapy in these patients should not be prematurely discounted because the prognosis of surgical patients compares favorably with that of nonsurgical patients, and because the severity of disabling angina was consistently reduced postoperatively.
There are obvious limitations in determining the benefits of surgery by noting a reduction in angina because of the highly subjective nature of this type of evaluation. However, up to now, the main purpose of surgery has been the relief of anginal pain. Previous reports from this'5 and other institutions33 34 35 that approximately 90% of patients experience a reduction in angina for more than a year after bypass grafting are further substantiated here. In addition, clinical improvement was found to be fairly durable: of the patients followed for at least four years, 75% continued to remain in FC I and II. It seems likely that further improvement in late results will be noted in the future. The more complete revascularization performed in recent years has been associated with proportionately more early FC I results and fewer FC III and IV results. Thus, since the recent cohorts are improved over the earlier ones, the proportion of long term good results can be expected to increase with time.
Previous studies38 37, 38 have demonstrated a close relationship between patent grafts and objective evidence of increased exercise capacity. In the present study, a highly significant relationship (P < 0.001) ( 
